OSSIO
Eyal Shmilovich is a Financial Controller and FP&A Lead at OSSIO since January 2022. Prior to joining OSSIO, Eyal worked as a Business Analyst at HP from July 2019 to February 2022. Before their time at HP, Eyal served as a Senior Consultant in Transaction Advisory Services at EY from January 2017 to July 2019. Eyal also gained experience in the Accounting Department at the Israel Ministry of Tourism from December 2013 to November 2016. Eyal holds a Bachelor's degree in Accounting and Economics from The Hebrew University of Jerusalem, obtained between 2012 and 2015.
This person is not in any teams
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.